Non–Small Cell Lung Cancer Coverage from Every Angle

Walter J. Curran, MD, on Stage III NSCLC

Posted: Monday, March 20, 2017

Walter J. Curran, MD, of Emory University, summarizes his keynote address on clinical trials in non-small cell lung cancer—lessons learned and the path forward with targeted treatments and checkpoint inhibitors in combination with radiation and chemotherapy.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.